Role of ion channels in the pathophysiology of ischemic heart disease: from genetics, to molecular expression, to clinical phenotype

被引：0

作者：

Severino, Paolo ^{[1
]}

DAmati, Andrea ^{[1
]}

Lucrezia, Netti ^{[1
]}

Pucci, Maria Teresa ^{[1
]}

Mariani, Marco Valerio ^{[1
]}

Birtolo, Lucia Ilaria ^{[1
]}

De Orchi, Paolo ^{[1
]}

Cimino, Sara ^{[1
]}

Maestrini, Viviana ^{[1
]}

Mancone, Massimo ^{[1
]}

Fedele, Francesco ^{[1
]}

Miraldi, Fabio ^{[1
]}

Infusino, Fabio ^{[1
]}

Palmirotta, Raffaele ^{[2
]}

Lovero, Domenica ^{[2
]}

Silvestris, Franco ^{[2
]}

Caputo, Viviana ^{[3
]}

Pizzuti, Antonio ^{[3
]}

机构：

[1] Sapienza Univ Rome, Dept Clin Internal Anaesthesiol & Cardiovasc Sci, Rome, Italy

[2] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Sect Clin & Mol Oncol, Bari, Italy

[3] Sapienza Univ Rome, Policlin Umberto I Hosp, Dept Expt Med, Rome, Italy

来源：

EUROPEAN HEART JOURNAL SUPPLEMENTS | 2020年 / 22卷 / 0N期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

538

引用

页码：N110 / N110

页数：1

共 50 条

[31] The clinical role of platelet glycoprotein IIb/IIIa receptor inhibitors in ischemic heart disease
Lefkovits, J
Topol, EJ
CLEVELAND CLINIC JOURNAL OF MEDICINE, 1996, 63 (03) : 181 - 189
[32] Potential Role of eNOS Genetic Variants in Ischemic Heart Disease Susceptibility and Clinical Presentation
Severino, Paolo
D'Amato, Andrea
Prosperi, Silvia
Magnocavallo, Michele
Mariani, Marco Valerio
Netti, Lucrezia
Birtolo, Lucia Ilaria
De Orchi, Paolo
Chimenti, Cristina
Maestrini, Viviana
Miraldi, Fabio
Lavalle, Carlo
Caputo, Viviana
Palmirotta, Raffaele
Mancone, Massimo
Fedele, Francesco
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (09)
[33] Genetics of Wilson disease and Wilson-like phenotype in a clinical series from eastern Spain
Sanchez-Monteagudo, Ana
Alvarez-Sauco, Maria
Sastre, Isabel
Martinez-Torres, Irene
Lupo, Vincenzo
Berenguer, Marina
Espinos, Carmen
CLINICAL GENETICS, 2020, 97 (05) : 758 - 763
[34] Hereditary dysfunction of voltage-gated sodium channels: From clinical phenotype to molecular mechanisms
George, AL
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (09) : 1730 - 1737
[35] ROLE OF NON-INVASIVE METHODS IN CLINICAL EVALUATION OF DRUGS IN ISCHEMIC HEART-DISEASE
CHLEBUS, H
BIBLIOTHECA CARDIOLOGICA, 1976, (35) : 167 - 171
[36] High heart rate and chronic ischemic heart disease. Lessons from a clinical practice survey
Barrios, V.
Escobar, C.
Murga, N.
de Pablo, C.
Bertoroeu, V.
Calderon, A.
JOURNAL OF HYPERTENSION, 2008, 26 : S156 - S156
[37] Disease-associated changes in the expression of ion channels, ion receptors, ion exchangers and Ca2+-handling proteins in heart hypertrophy
Zwadlo, C
Borlak, J
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 207 (03) : 244 - 256
[38] SUDDEN CARDIAC DEATH IN PATIENTS WITH ISCHEMIC HEART DISEASE: FROM MECHANISMS TO CLINICAL PRACTICE
Golukhova, E. Z.
Gromova, O., I
Bulaeva, N., I
Bokeria, L. A.
KARDIOLOGIYA, 2017, 57 (12) : 73 - 81
[39] Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease
Bourgeois, Florence T.
Orenstein, Liat
Ballakur, Sarita
Mandl, Kenneth D.
Ioannidis, John P. A.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 (11) : 2354 - 2361
[40] Depression and ischemic heart disease: what have we learned from clinical trials?
Rivelli, Sarah
Jiang, Wei
CURRENT OPINION IN CARDIOLOGY, 2007, 22 (04) : 286 - 291

← 1 2 3 4 5 →